Drug and Therapeutics Bulletin 2006;44:21-24; doi:10.1136/dtb.2006.44321
Copyright © 2006 by the BMJ Publishing Group Ltd.
Endpoints in asthma drug trials - what do they mean?
There are many potential outcomes or endpoints to choose from to assess the effects of asthma treatments, and a wide range of such measures are used in different trials. This can make it difficult to compare treatment outcomes from different trials and to understand whether new treatments offer a genuine clinical benefit for patients. Here we review the common endpoints used in trials to assess the efficacy of asthma treatments.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
- Full Text
- Full Text (PDF)
- Submit a response
- Alert me when this article is cited
- Alert me when eLetters are posted
- Alert me if a correction is posted
Services
- Email this link to a friend
- Similar articles in this journal
- Similar articles in PubMed
- Add article to my folders
- Download to citation manager
- Request Permissions
Citing Articles
Google Scholar
PubMed
Topic Collections
-
Respiratory system
-
Malignant disease and immunosuppression
-
Haematology (drugs and medicines)
-
Ear, nose and throat
-
Immunological products and vaccines
Bookmark with
Register for email alerts
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
Coming soon!
The DTB archive back to 1962, volume 1, issue 1 will soon be available.
